...
首页> 外文期刊>TMR Theory and Hypothesis >A case of lung primary angiosarcoma's treatment by Keytruda
【24h】

A case of lung primary angiosarcoma's treatment by Keytruda

机译:Keytruda治疗肺原发性血管肉瘤1例

获取原文

摘要

Primary pulmonary angiosarcoma is rare, accounting for about 2% of all lung tumors. Male incidence is five times highe -r than female. The clinical symptoms and imaging findings of pulmonary angiosarcoma are nonspecific and can be diag nosed by immunohistochemistry. The treatment of pulmonary angiosarcoma has not yet been defined, including surgery, chemotherapy, radiotherapy, poor prognosis, high mortality, most patients died within a few months after symptoms. Ste roids, cyclophosphamide, gemcitabine and paclitaxel have been reported to be used in maintenance chemotherapy. The p atient survived for one year and then died. A case of primary pulmonary angiosarcoma were treated with keytruda, and t he literature was reviewed.
机译:原发性肺血管肉瘤很少见,约占所有肺肿瘤的2%。男性发病率是女性的五倍。肺血管肉瘤的临床症状和影像学表现是非特异性的,可以通过免疫组织化学诊断。肺血管肉瘤的治疗方法尚未确定,包括手术,化学疗法,放疗,预后差,死亡率高,大多数患者在症状出现后的几个月内死亡。据报道,类固醇,环磷酰胺,吉西他滨和紫杉醇可用于维持化疗。患者存活了一年,然后死亡。 1例原发性肺血管肉瘤用Keytruda治疗,并复习文献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号